DB 368
Latest Information Update: 27 Nov 2007
At a glance
- Originator Immtech Pharmaceuticals; Nonindustrial source
- Class Antifungals
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 14 Oct 2002 No development reported - Preclinical for Mycoses in USA (unspecified route)
- 16 May 2000 Preclinical development for Mycoses in USA (Unknown route)